STEPANKOVA, Lenka, Eva KRALIKOVA, Kamila ZVOLSKA, Alexandra PANKOVA, Petra OVESNÁ, Milan BLAHA a Leonie S. BROSE. Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. ANNALS OF BEHAVIORAL MEDICINE. New York: Springer, roč. 51, č. 3, s. 454-463. ISSN 0883-6612. doi:10.1007/s12160-016-9869-6. 2017.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up
Autoři STEPANKOVA, Lenka (203 Česká republika), Eva KRALIKOVA (203 Česká republika), Kamila ZVOLSKA (203 Česká republika), Alexandra PANKOVA (203 Česká republika), Petra OVESNÁ (203 Česká republika, garant, domácí), Milan BLAHA (203 Česká republika, domácí) a Leonie S. BROSE (826 Velká Británie a Severní Irsko).
Vydání ANNALS OF BEHAVIORAL MEDICINE, New York, Springer, 2017, 0883-6612.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 50101 Psychology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.118
Kód RIV RIV/00216224:14110/17:00096930
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s12160-016-9869-6
UT WoS 000401922100013
Klíčová slova anglicky Smoking cessation; Depression; Cohort study; Preventive health services; Effectiveness; Evidence-based practice
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 20. 3. 2018 12:14.
Anotace
Smoking is more prevalent among people with depression. Depression may make cessation more difficult and cessation may affect depression symptoms. The aims of this study were to assess the associations between (1) baseline depression and 1-year smoking abstinence and (2) abstinence and change in depression. Observational study using data collected routinely in a smoking cessation clinic in the Czech Republic from 2008 to 2014. Aim 1: N = 3775 patients; 14.3% reported mild and 15.4% moderate/severe baseline depression levels measured using Beck's Depression Inventory (BDI-II). Logistic regressions assessed if depression level predicted 1-year biochemically verified abstinence while adjusting for patient and treatment characteristics. Aim 2: N = 835 patients abstinent at 1 year; change in depression was analysed using Chi-square statistics, t test and mixed method analyses of variance. Rate of abstinence was lower for patients with mild (32.5%, OR = 0.68; 95% CI: 0.54 to 0.87, p = 0.002) and moderate/severe depression (25.8%; OR = 0.57, 95% CI: 0.45 to 0.74, p < 0.001) compared with patients without depression (40.5%). Across abstinent patients, the majority with baseline depression reported lower depression levels at follow-up. Overall mean (SD) BDI-II scores improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. There were significant main effects of time (F(1832) = 880.8, p < 0.001, partial eta(2) = 0.51) and baseline depression level (F(2832) = 666.4, p < 0.001, partial eta(2) = 0.62) on follow-up depression and a significant depression * time interaction (F(2832) = 296.5, p < 0.001, partial eta(2) = 0.42). In this effective smoking cessation clinic, depression at the start of treatment predicted reduced smoking abstinence 1 year later. Patients abstinent from smoking experienced considerable improvement in depression.
VytisknoutZobrazeno: 20. 4. 2024 00:48